Bank Of New York Mellon Corp Gelesis Holdings, Inc. Transaction History

Bank Of New York Mellon Corp

  • $538 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023
BUY
$0.11 - $0.52 $4,302 - $20,337
39,111 New
39,111 $6.36 Million
Q4 2022

Feb 14, 2023
BUY
$0.22 - $0.51 $12,294 - $28,500
55,884 New
55,884 $16,000
Q3 2022

Nov 14, 2022
BUY
$0.08 - $1.34 $1,476 - $24,728
18,454 Added 49.3%
55,884 $60,000
Q2 2022

Aug 15, 2022
BUY
N/A
37,430 New
37,430 $58,000

Others Institutions Holding GLS

# of Institutions
1
Shares Held
4.7K
Call Options Held
0
Put Options Held
0
View Full List

About GELESIS HOLDINGS, INC.

GLS Quotes by TradingView
  • Ticker GLS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 72,946,704
  • Market Cap $1.46M
  • Description
  • Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipelin...
More about GLS
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email